Results 211 to 220 of about 44,727 (269)

Prevalence of recurrent and non-recurrent BRCA1 and BRCA2 pathogenic variants in Polish breast cancer patients: insights from a regional genetic testing cohort from Lower Silesia. [PDF]

BMC Cancer
Matkowski R, Abrahamowska M, Michalowska D, Chrusciel A, Szelachowska J, Blomka D, Lawicka P, Czykalko E, Pietron A, Ekiert M, Doraczynska-Kowalik A, Janus-Szymanska G, Kasprzak P, Szynglarewicz B, Laczmanska I.   +14 more
europepmc   +1 more source

A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2. [PDF]

Clin Cancer Res
Huffman BM, Diossy M, Yurgelun MB, Horick N, Li YY, Crowdis J, Nguyen H, Parmar K, Kochupurakkal BS, Vonk L, Lam H, Ramsey K, Andrews E, Loeb SC, Culnane L, Biller LH, Bullock AJ, Enzinger A, Giannakis M, Jackson NA, Ng K, Nowak JA, Patel AK, Perez KJ, Rattani A, Rubinson DA, Schlechter BL, Singh H, Cai M, Raghavan S, Clark JW, Peters ML, Weipert CM, Wolpin BM, D'Andrea AD, Shapiro GI, Aguirre AJ, Szallasi Z, Cleary JM.   +38 more
europepmc   +1 more source

Commentary: With Regards to the WISDOM trial. [PDF]

BJC Rep
Narod SA.
europepmc   +1 more source

Identification of Genetic Variants Among Breast Cancer Patients and At-Risk Individuals: A Cohort Study in Sri Lanka. [PDF]

Breast Cancer (Auckl)
Yatawara L, Hewavithana B, Ramanayake AP, Wickramasinghe S, Amarasiri M.   +4 more
europepmc   +1 more source

Germline Genetic Testing in Breast and Gynecologic Cancers: Evaluating Age at Diagnosis as a Determinant. [PDF]

Cancers (Basel)
Papadopoulou E, Tsaousis GN, Alevizou R, Alexandrou D, Argyriou T, Giannopoulou A, Thanos M, Kakoulaki S, Kalyvopoulos C, Kanara M, Kanistras C, Katsiakis N, Katsourakis A, Kokkonis D, Kontoulis T, Konstantiadou I, Tryfonopoulos D, Karageorgopoulou S, Koumarianou A, Ziogas D, Bikos S, Bompou E, Boutsikos G, Pantelidou V, Savvidou A, Sakellariou V, Matiatou M, Karathanasis P, Stathoulopoulou M, Venizelos V.   +29 more
europepmc   +1 more source

Homologous recombination deficiency and genomic alterations in advanced prostate cancer: insights for precision therapy. [PDF]

Oncologist
Mercinelli C, Pavlick D, Agarwal N, Spiess PE, Li R, Kamat AM, Grivas P, Gupta S, Maiorano BA, Tateo V, Cigliola A, Piacentini M, Jacob JM, Bratslavsky G, Basnet A, Ross JS, Necchi A.   +16 more
europepmc   +1 more source

Exploring the somatic mutational landscape of ovarian cancer in Estonia. [PDF]

Acta Oncol
Tooming M, Rekker K, Toome K, Roht L, Laidre P, Fjodorova O, Šamarina U, Pajusalu S, Ilisson M, Peets P, Jõgi T, Klaup K, Ojamaa K, Niine-Roolaht EM, Kaarde P, Vettus E, Piirsoo J, Vahar H, Õunap K, Kahre T.   +19 more
europepmc   +1 more source

Exploring alternatives to tumor tissue for BRCA1/2 next-generation sequencing testing in high-grade serous ovarian cancer: A 34-case series of malignant ascites. [PDF]

Cancer Cytopathol
Pighi C, Settanni G, Angelini M, Bortesi L, Viassolo V, Ceccaroni M, Bruni F, Gori S, Zannoni GF, Pesci A.   +9 more
europepmc   +1 more source

BRCA1/2 and CHEK2 Pathogenic Variants in Urological Cancers: A Portuguese Single-Center Experience. [PDF]

Cureus
Quinto Pereira M, Miguel I, Fragoso S, Duarte T, Santos S, Rodrigues P, Pereira C, Vaz F.   +7 more
europepmc   +1 more source

Genetic Testing in Breast Cancer: Narrative Review and Clinical Insights. [PDF]

Maedica (Bucur)
Bistriceanu I, Ungureanu CO, Stoica RA, Giuglea C, Grigorean VT, Roca D, Mihaila R, Iordache N, Ginghina O.   +8 more
europepmc   +1 more source